Lupin acquires Australia's Southern Cross Pharma

As a part of the transaction, Lupin's Australia subsidiary Generic Health will gain access to over 60 registered products having sales of over $22 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news